How and why study designs affect the nature and validity of study results: Appearance versus true knowledge. part i

Journal of Psychiatric Practice

Volumn 15, Issue 4, 2009, Pages 306-310

  Preskorn, Sheldon H ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

Antidepressants; Clinical trial design; Selective serotonin reuptake inhibitors

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYTOCHROME P450 2D6; PAROXETINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; BINDING AFFINITY; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; GENETIC POLYMORPHISM; HUMAN; INTENSIVE CARE; METHODOLOGY; NONHUMAN; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACOGENETICS; PLACEBO EFFECT; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SEROTONIN BRAIN LEVEL; STRUCTURE ACTIVITY RELATION; TREATMENT RESPONSE; VALIDITY;

ATTITUDE; CLINICAL COMPETENCE; CYTOCHROME P-450 CYP2D6; DEPRESSIVE DISORDER, MAJOR; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 68949176844     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000358316.96555.f2     Document Type: Article

References (15)

1. Preskorn SH. Outpatient management of depression, third edition. Caddo, OK: Professional Communications; 2009.
2. Ereshefsky L, Jhee S, Grothe D. Antidepressant drug-drug interaction profile update. Drugs R D 2005;6:323-336
3. Ereshefsky L, Culpepper L, Preskorn SH. The use of phar-macotherapy for depression: The importance of drug-drug interactions. Clinical Symposia 2009;59:1-3.
4. Spina E, Santoro V, D'Arrigo C. Clinically relevant phar-macokinetic drug interactions with second-generation antidepressants: An update. Clin Ther 2008;30:1206-1227
5. Flockhart DA. Drug interactions: Cytochrome P450 drug interaction table. Indiana University School of Medicine 2007 (can be accessed at http://medicine.iupui.edu/clin-pharm/ddis/table.asp)
6. Fredman SJ, Fava M, Kienke AS, et al. Partial response, nonresponse, and relapse with selective serotonin reup-take inhibitors in major depression: A survey of current "next-step" practices. J Clin Psychiatry 2000;61:403-408
7. Ruhé HG, Huyser J, Swinkels JA, et al. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: A systematic review. J Clin Psychiatry 2006;67:1836-1855 (Pubitemid 46055194)
8. Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: A meta-analysis comparing within-versus across-class switches. Biol Psychiatry 2008;63: 699-704.
9. Preskorn SH. Treatment options for the patient who does not respond well to initial antidepressant therapy. J Psychiatr Pract 2009;15:202-210
10. Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006;354:1231-1242
11. Preskorn SH, Baker B, Kolluri S, et al. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol 2008; 28:631-637
12. Preskorn SH. Clinical pharmacology of SSRIs. Caddo, OK: Professional Communications; 1996 (available at www.preskorn.com/books/ssri-open.html).
13. Meyer JH, Wilson AA, Sagrati S, et al. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: An [11C]DASB positron emission tomography study. Am J Psychiatry 2004;161:826-835
14. Kurnik D, Li C, Sofowora GG, Friedman EA, et al. Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. Pharmacogenet Genomics 2008; 18:895-902.
15. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: Variable, substantial, and growing. JAMA 2002;287:1840-1847